Science, Politics, And The Human Costs Of Defeating Disease

Jun 9, 2017

Until the late 1960s, tens of thousands of American children suffered crippling birth defects if their mothers had been exposed to rubella, popularly known as German measles, while pregnant; there was no vaccine and little understanding of how the disease devastated fetuses. In June 1962, a young biologist in Philadelphia, using tissue extracted from an aborted fetus from Sweden, produced safe, clean cells that allowed the creation of vaccines against rubella and other common childhood diseases. Two years later, in the midst of a devastating German measles epidemic, his colleague developed the vaccine that would one day wipe out homegrown rubella. The rubella vaccine and others made with those fetal cells have protected more than 150 million people in the United States, the vast majority of them preschoolers. 

Meredith Wadman covered biomedical research politics from Washington for twenty years. She is a reporter at  Science and has written for NatureFortune, the New York Times, and the Wall Street Journal. A graduate of Stanford and Columbia, she began medical school at the University of British Columbia and completed her medical degree as a Rhodes scholar at the University of Oxford.

Her new book is The Vaccine Race: Science, Politics, and the Human Costs of Defeating Disease